UBS AM
BNGO icon

UBS AM’s Bionano Genomics BNGO Stock Holding History

UBS AM’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-334
Closed -$222K – 2606
2023
Q2 		$222K Hold
334
– – ﹤0.01% 2549
2023
Q1 		$222K Sell
334
-234
-41% -$208K ﹤0.01% 2549
2022
Q4 		$498K Hold
568
– – ﹤0.01% 2178
2022
Q3 		$624K Buy
568
+1
+0.2% +$1.32K ﹤0.01% 2242
2022
Q2 		$470K Buy
567
+118
+26% +$121K ﹤0.01% 2342
2022
Q1 		$695K Hold
449
– – ﹤0.01% 2322
2021
Q4 		$805K Buy
449
+69
+18% +$185K ﹤0.01% 2325
2021
Q3 		$1.26M Buy
380
+12
+3% +$42K ﹤0.01% 2044
2021
Q2 		$1.62M Buy
+368
New +$1.45M ﹤0.01% 1950

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS AM's BNGO Position: Q3 2023 in Review

UBS AM sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 334 shares — an estimated $222K sold.

UBS AM first reported a position in BNGO in Q2 2021 and held it in 9 quarters. The position peaked at $1.62M in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • UBS AM reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • UBS AM sold 334 Bionano Genomics shares in Q3 2023, an estimated $222K.
  • UBS AM first reported a position in Bionano Genomics in Q2 2021 and held it in 9 quarters.
  • UBS AM's Bionano Genomics position peaked at $1.62M in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.